Laboratory Reference Grade Compounds

DIHEXA

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱2,520.00
In Stock · Dispatches 24h
Net Content10MG
InclusionVial + BAC Water
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (10MG)
Diluent:mL
Concentration10.00 mg/mLin 1.0mL BAC
Standard Dose5.0 mg – 10.0 mg daily (5000 mcg – 10000 mcg)Syringe: 1.00 mL (5 mg)
Scale (1 Unit)100 mcgper 0.01 mL (U-100)
✓ Includes 10mL Bacteriostatic Water USPMonograph SOP →
DIHEXA10MG · Vial + BAC Water
₱2,520.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

What it is: Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is an orally active, blood-brain barrier-permeable small-molecule peptide derivative developed at Washington State University.

How it works: Dihexa binds with high affinity to Hepatocyte Growth Factor (HGF) and its receptor c-Met. Remarkably, in preclinical assays, Dihexa was found to be orders of magnitude more potent than BDNF at inducing spinogenesis—the physical creation of new dendritic spines and synaptic connections between neurons.

Why researchers study it: Researched for reversing severe cognitive deficits, Alzheimer's and Parkinson's disease, traumatic brain injury, and building vast new synaptic networks in the brain.

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryCognitive & Neuroprotective
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry Number1401708-83-5
PubChem CID129010512↗
Molecular Weight504.66 g/mol
Purity Specification≥99.0% (HPLC-grade)
Net Content Options10MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set, Nasal Complete Set
Peptide Sequence / FormulaN-hexanoic-Tyr-Ile-(6)aminohexanoic amide (C27H44N4O5)